Impact of genetic polymorphisms of VEGF pathway on the response to bevacizumab in metastatic colorectal cancer (mCRC): Ancillary study of PRODIGE 9 trial.

Affiliation auteurs!!!! Error affiliation !!!!
TitreImpact of genetic polymorphisms of VEGF pathway on the response to bevacizumab in metastatic colorectal cancer (mCRC): Ancillary study of PRODIGE 9 trial.
Type de publicationJournal Article
Year of Publication2016
AuteursSibertin-Blanc C, Fabre A, Aparicio T, Le Malicot K, Bennouna J, Ghiringhelli F, Taieb J, Boige V, Bouche O, Faroux R, Francois E, Jacquot S, Genet D, Khemissa F, Cany L, Bachet JBaptiste, Mulot C, Seitz JFrancois, Olschwang S, Dahan L
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2016.34.15_suppl.3534